H. Richard Alexander
- Oncology top 0.2%
- Pancreatic and Hepatic Oncology Research 33
- Neurology top 0.5%
- Neuroblastoma Research and Treatments 22
- Epidemiology top 0.5%
- Neuroendocrine Tumor Research Advances 42
- Cancer Research top 1%
- Immunology top 1%
-
- Intraperitoneal and Appendiceal Malignancies 28
-
- Hepatocellular Carcinoma Treatment and Prognosis 26
-
- Virus-based gene therapy research 24
-
- Occupational and environmental lung diseases 22
-
- Angiogenesis and VEGF in Cancer 18
- Co-authors
- Steven K. LibuttiDouglas L. FrakerJeffrey A. NortonDavid VenzonRobert T. JensenDavid L. BartlettJames F. PingpankEwa M. Turner
- Cited by
- OncologyNeurologyEpidemiology
- Journals
- Science (1 paper)New England Journal of Medicine (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesGermanyMalaysia
In The Last Decade
H. Richard Alexander
227 papers receiving 13.4k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Oncology 4.9k
- Neurology 1.8k
- Epidemiology 3.8k
- Cancer Research 1.6k
- Immunology 2.0k
Countries citing papers authored by H. Richard Alexander
This map shows the geographic impact of H. Richard Alexander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Richard Alexander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Richard Alexander more than expected).
Fields of papers citing papers by H. Richard Alexander
This network shows the impact of papers produced by H. Richard Alexander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Richard Alexander. The network helps show where H. Richard Alexander may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H. Richard Alexander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2018 | 14 | |
| 3 | 2016 | 40 | |
| 4 | 2016 | 225 | |
| 5 | 2013 | 37 | |
| 6 | 2013 | 245 | |
| 7 | 2013 | 105 | |
| 8 | 2013 | 21 | |
| 9 | 2013 | 31 | |
| 10 | 2008 | 99 | |
| 11 | 2008 | 34 | |
| 12 | 2004 | 29 | |
| 13 | 2002 | 7 | |
| 14 | 2001 | 90 | |
| 15 | 2000 | 128 | |
| 16 | 1997 | 22 | |
| 17 | 1995 | 11 | |
| 18 | 1993 | 39 | |
| 19 | 1992 | 39 | |
| 20 | 1991 | 125 |
About H. Richard Alexander
H. Richard Alexander is a scholar working on Hepatology, Oncology and Nephrology, having authored 229 papers that have together received 13.8k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (42 papers), Pancreatic and Hepatic Oncology Research (33 papers), Intraperitoneal and Appendiceal Malignancies (28 papers), Hepatocellular Carcinoma Treatment and Prognosis (26 papers), Virus-based gene therapy research (24 papers), Occupational and environmental lung diseases (22 papers), Neuroblastoma Research and Treatments (22 papers) and Angiogenesis and VEGF in Cancer (18 papers). The work is most often cited by research in Oncology (4.9k citations), Neurology (1.8k citations) and Epidemiology (3.8k citations). H. Richard Alexander has collaborated with scholars based in United States, Germany and Malaysia. Frequent co-authors include Steven K. Libutti, Douglas L. Fraker, Jeffrey A. Norton, David Venzon, Robert T. Jensen, David L. Bartlett, James F. Pingpank, Ewa M. Turner, Gerard M. Doherty and Fathia Gibril. Their work appears in journals such as Science, New England Journal of Medicine and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.